FULCRUM THERAPEUTICS
3.5700
07-October-24 14:59:58
15 minutes delayed
Stocks
-0.2500
-6.54%
Today's range
3.5500 - 3.7800
ISIN
N/A
Source
NASDAQ
-
09 Apr 2021 12:15:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Judith A. Dunn, Ph.D. as President of Research and Development
24 Mar 2021 08:29:00 By Nasdaq GlobeNewswire
-
04 Mar 2021 06:01:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 Mar 2021 06:00:01 By Nasdaq GlobeNewswire
-
26 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Recognizes Rare Disease Day 2021
26 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in Upcoming Investor Conferences
19 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
22 Jan 2021 15:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
19 Jan 2021 21:34:02 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
19 Jan 2021 15:01:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Promotion of Christopher Moxham, Ph.D., to Chief Scientific Officer
19 Jan 2021 15:00:00 By Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate in the H.C. Wainwright BioConnect 2021 Conference
06 Jan 2021 06:00:00 By Nasdaq GlobeNewswire